For BPC-157, the agency cited the potential for immunogenicity, peptide-related impurities, problems characterizing the active ingredient, and a lack of safety data for the proposed routes of administration
Clinical Trials and Studies Dr
During his training, he performed over 2000 procedures covering a multitude of competencies including surgery of the hand, craniomaxillofacial reconstruction, breast reconstruction, nerve surgery, limb salvage, and non-surgical facial rejuvenation
molecules that target heat shock protein70 and p53 inhibitors
doi: 10.1186/s13048-022-00965-7 100 ZhangJLiuYYaoWLiQLiuHPanZ
77 LiP.YangX.ChengY.ZhangX.YangC.DengX.et al (2017)